Fabry Disease


Start of phase I clinical trial for moss-aGal, the world´s first moss-produced drug candidate ...

Learn more

aHUS disease


is a recombinant protein in development as a treatment for atypical Haemolytic Uremic Syndrome (aHUS) ...

Learn more

Products & Services


Based on our innovative BryoTechnology platform, we have established a pipeline of proprietary clinical candidates …

Learn more

News & Events

BIO-Europe Spring

Barcelona, Spain

March 20 – March 22, 2017